Transepithelial transport of bepridil in the human intestinal cell line, Caco-2, using a "dynamic model"

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 28, Issue 2, 2003, Pages 155-160

  Mathieu, F ^a   Galmier, M J ^a,b   Nicolay, A ^a   Pognat, J F ^a   Lartigue, C ^a  

^a INSERM   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Bepridil; Caco 2; Dynamic model; Transport

Indexed keywords

BEPRIDIL;

ARTICLE; BASOLATERAL MEMBRANE; BINDING SITE; CELL ADHESION; CELL COMPARTMENTALIZATION; CELL MEMBRANE TRANSPORT; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BINDING; DRUG DETERMINATION; DRUG HALF LIFE; DRUG TRANSPORT; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; INTESTINE CELL; INTESTINE EPITHELIUM CELL; MASS SPECTROMETRY; THEORETICAL MODEL;

EID: 0038780860     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190505     Document Type: Article

References (16)

1. Boulenc X. (1997): Intestinal cell models. Their use in evaluating the metabolism and absorption of xenobiotics. STP. Pharm. Sci., 7(4), 259269.
2. Stammati A, Badino P, De Angelis I et al. (1997): in vitro toxicity and formation of early conjugates in Caco-2 cell line treated with clenbuterol, salbutamol and isoxsuprine. Eur. J. Drug Metab. Pharmacokinet., 22(2), 173-178.
3. Buur A, Trier, L, Magnusson C, Artursson P. (1996): Permeability of 5-fluorouracil and prodrugs in Caco-2 cell monolayers. Int. J. Pharm., 129, 223-231.
4. Chong S, Dando SA, Soucek KM, Morison RA. (1996): in vitro permeability through Caco-2 cells is not quantitatively predictive of in vivo absorption for peptide-like drugs absorbed via the dipeptide transporter system. Pharm. Res., 13(1), 120-123.
5. Cogburn J N, Donovan MG, Schasteen CS. (1991): A model of human small intestinal absorptive cells. 1. Transport barrier. Pharm. Res., 8(2), 210-216.
6. Collett A, Sims E, Walker D, et al. (1996): Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption. Pharm. Res., 13(2), 216-221.
7. Hilgers AR, Conradi RA, Burton PS. (1990): Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm. Res., 7(9), 902-910.
8. Karlsson J, Kuo S-M., Ziemniak J, Artursson P. (1993): Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein. Br. J. Pharmacol., 110, 1009-1016.
9. Lindmark T, Nikkilä T, Artursson P. (1995): Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers. J. Pharmacol. Exp. Th., 275(2), 958-964.
10. Raub TJ, Barsuhn CL, Williams LR, Decker DE, Sawada GA, Ho NFH. (1993): Use of a biophysical-kinetic model to inderstand the roles of protein binding and membrane partitioning on passive diffusion of highly lipophilic molecules across cellular barriers. J. Drug Target., 1, 269-286
11. Krishna G, Chen K, Lin C-C, Nomeir A-A. (2001): Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2. Int. J. Pharm., 222, 77-89.
12. Sawada GA, Ho NFH, Williams LR, Barsuhn CL, Raub TJ. (1994): Transcellular Permeability of Chlorpromazine Demonstrating the Roles of Protein Binding and Membrane Partitioning. Pharm. Res., 11 (5), 665-673.
13. Tillement JP, Albengres E, Lhost F. (1982): Bepridil. Rev. Med., 23, 1637-1640.
14. Mathieu F, Galmier M-J, Pognat J-F, Petit J, Lartigue C. (1999): Transepithelial transport of bepridil in the human cell line, Caco-2, using two media DMEMc and HBSS. Int. J. Pharm., 181, 203-217.
15. Sakai M, Noach A-B, Blom-Roosemalen M-C-M, De Boer A-G, Breimer D-D. (1994): Absorption enhancement of hydrophilic compounds by verapamil in Caco-2 cell monolayers. Biochem. Pharmacol., 48(6), 1199-1210.
16. Stenson W-F, Easom R-A, Riehl T-E, Turk J. (1993): Regulation of paracellular permeability in Caco-2 cell monolayers by protein kinase C. Am. J. Physiol., 265, G955-G962